Linezolid Teva

Linezolid, the active ingredient in Linezolid Teva, is an oxazolidinone presented as a strength/form for oral use. It treats Gram‑positive bacterial infections, including methicillin‑resistant Staphylococcus aureus (MRSA), community‑acquired bacterial pneumonia, and skin and soft‑tissue infections.

GNH USA supplies Linezolid Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linezolid is an oxazolidinone antibiotic used to manage infections caused by Gram‑positive bacteria. - Gram‑positive bacterial infections: provides bacteriostatic activity against resistant strains. - Methicillin‑resistant Staphylococcus aureus (MRSA): clears skin, bloodstream and respiratory infections. - Community‑acquired bacterial pneumonia: resolves pulmonary infection caused by susceptible organisms. - Skin and soft‑tissue infections: treats cellulitis, abscesses and wound infections.

Linezolid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: transient gastrointestinal upset. - Diarrhea: loose stools, usually self‑limited. - Headache: mild to moderate intensity. - Metallic taste: altered taste perception during therapy.

Serious or Rare Side Effects: - Thrombocytopenia: significant drop in platelet count requiring monitoring. - Peripheral neuropathy: sensory changes that may be irreversible. - Serotonin syndrome: risk when combined with serotonergic agents. - Lactic acidosis: rare metabolic disturbance with high morbidity.

Before initiating Linezolid, clinicians should consider several safety measures. - Monitor blood counts: watch for thrombocytopenia and anemia. - Assess renal function: adjust use in severe impairment. - Avoid serotonergic drugs: risk of serotonin syndrome. - Use with caution in hepatic disease: limited metabolism may increase exposure. - Store at room temperature below 25°C: keep in the original pack, protect from moisture.

Linezolid interacts with several drug classes; awareness helps prevent adverse events.

Major Interactions (Avoid): - MAO inhibitors: can cause hypertensive crisis. - Serotonergic agents (SSRIs, SNRIs, tricyclics): increase risk of serotonin syndrome.

Moderate Interactions (Monitor Closely): - Rifampin: induces metabolism, reducing linezolid levels. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Anticonvulsants (e.g., carbamazepine): may lower linezolid concentrations.